thiophenes has been researched along with Arterial Diseases, Carotid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, K; Higashi, Y; Inoue, T; Ishizu, T; Kadokami, T; Kario, K; Kitakaze, M; Kodera, S; Maemura, K; Matsuhisa, M; Murohara, T; Nanasato, M; Nishio, Y; Node, K; Ohishi, M; Oyama, J; Sata, M; Sato, Y; Shimabukuro, M; Suzuki, M; Taguchi, I; Tanaka, A; Teragawa, H; Tomiyama, H; Ueda, S; Yamada, H | 1 |
| Ali, MI; Anea, CB; Merloiu, AM; Osmond, JM; Rudic, RD; Stepp, DW; Sullivan, JC | 1 |
| Crosby-Nwaobi, R; Drozdov, I; Dudek, K; Kaudewitz, D; Kiechl, S; King, A; Kirkby, NS; Langley, SR; Markus, HS; Mayr, M; Mitchell, JA; Prokopi, M; Sivaprasad, S; Warner, TD; Willeit, P; Zampetaki, A | 1 |
1 trial(s) available for thiophenes and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.
Topics: Adult; Aged; Biomarkers; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Prospective Studies; Research Design; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2016 |
2 other study(ies) available for thiophenes and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Matrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice.
Topics: Animals; ARNTL Transcription Factors; Blood Pressure; Carotid Arteries; Carotid Artery Diseases; Cells, Cultured; Circadian Clocks; Elasticity; Endothelial Cells; Extracellular Matrix; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Myocytes, Smooth Muscle; Period Circadian Proteins; Phenylalanine; Protease Inhibitors; Thiophenes; Time Factors; Ultrasonography, Doppler, Pulsed | 2010 |
Circulating microRNAs as novel biomarkers for platelet activation.
Topics: Adult; Aspirin; Biomarkers; Blood Platelets; Blood Specimen Collection; Carotid Artery Diseases; Case-Control Studies; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Gene Expression Profiling; Humans; Male; MicroRNAs; Piperazines; Plasma; Platelet Activation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Prasugrel Hydrochloride; Real-Time Polymerase Chain Reaction; Serum; Thiophenes; Young Adult | 2013 |